$4.80
0.204.35%
Last update: Nov 6, 4:00 PM
CytoSorbents Corp (CTSO) Stock Price, Quote, News & History
CTSONASDAQ
CytoSorbents is progressing with U.S. FDA and Health Canada reviews for its DrugSorb-ATR device.
You can purchase shares of CytoSorbents (NASDAQ:CTSO) through any online brokerage.
Other companies in CytoSorbents’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
CytoSorbents has a consensus price target of $96.90.
The stock price for CytoSorbents (NASDAQ: CTSO) is $5.36 last updated October 28, 2026 at 7:05 PM EDT.
There are no upcoming dividends for CytoSorbents.
CytoSorbents does not have any upcoming earnings scheduled.
There is no upcoming split for CytoSorbents.
CytoSorbents is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous...
